Small Biotechs Could Suffer Under State Bans On Selling Physician Rx Data, BIO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Bans on the practice, like the recently upheld New Hampshire law, could have an unintended financial consequence on small biotech companies, BIO warns.